In this presentation, Dr. Simon Kung immerses us in the world of TMS. He reviews the basis of TMS, the FDA-approved devices and coils, and its potential side effects. Dr. Kung also reviews the evidence supporting the application of TMS in the treatment of depression, obsessive-compulsive disorder, and smoking cessation. To conclude his presentation, he provides insight into insurance companies’ criteria for TMS coverage and presents a clinical case study. This effectively illustrates the patient’s response to TMS treatment, their sustained improvement, the prescribed treatment regimen followed, and a plan designed to address possible relapse scenarios.
- Provider:Medical Academy, LLC
- Activity Link: https://psychopharmacologyinstitute.com/publication/tms-in-psychiatry-innovations-and-best-practices-2792?utm_source=PARS+ACCME&utm_medium=PARS+ACCME&utm_campaign=PARS+ACCME
- Start Date: 2024-04-01 05:00:00
- End Date: 2024-04-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Performance
- Provider Ship: Jointly Provided
- Registration: Limited
Subscribe
Login
0 Comments
Oldest